Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > ALS ONE Symposium - Presentation by Dr. Neil Cashman of PMN

View:

Post by DavidKingCanada on Dec 07, 2021 1:05pm

ALS ONE Symposium - Presentation by Dr. Neil Cashman of PMN

Excellent presentation at the Annual ALS ONE Symposium
Dated DEC-06-2021

Youtube URL

https://www.youtube.com/watch?v=Dq7EEV9dWhw

180

Comment

Comment by Speyeder999 on Dec 07, 2021 1:38pm

Nice find! Thanks for sharing

Comment

Comment by JackRedwood on Dec 07, 2021 1:49pm

Will have to watch it when I get home! Thanks

Comment

Comment by Bookworm28 on Dec 07, 2021 2:09pm

Good question at the 20 min mark, and another around the 23 min mark, followed by Neil's reply. That's the billion dollar question(s). Is it too late to save the cell after misfolding has occurred, even if the antibodies take care of the misfolded proteins, aka 'the bad guys'? Neil's response around the 23 min mark. 'Likely', and 'probably', sound encouraging ...more

119

Comment

ProMIS Neurosciences Inc